Persistent Post COVID-19 Symptoms and Functional Status After 12-14 Weeks of Recovery, Tamil Nadu, India, 2021

December 2021 in “ Journal of Infection ”

Polani Rubeshkumar, Alby John, Manish Narnaware, M Jagadeesan, Fermi Vidya, Rajeshkumar Gurunathan, P. Ganeshkumar, Gagandeep Singh Bedi, Prabhdeep Kaur

hair loss

TLDR One in four people still had symptoms like weight loss, hair loss, and fatigue 12-14 weeks after recovering from COVID-19.

The study conducted in Chennai, India, involved 1001 COVID-19 recovered patients and found that 25% of them reported at least one persistent symptom 12-14 weeks post-recovery. The most common symptoms were weight loss (40%), hair loss (29%), and fatigue (26%). Hospitalization due to severe infection and having at least one comorbidity were linked to these persistent symptoms. Specifically, severe infection led to significant limitations in daily activities post-recovery. Despite this, 87% of participants reported no functional limitations compared to their pre-COVID-19 state. However, 2% had reduced usual activities due to symptoms and anxiety, and 0.3% needed constant support for daily activities.

View this study on journalofinfection.com →

Discuss this study in the Community →

Similar Research

6 / 1000+ results

research Towards a Molecular Understanding of Hair Loss and Its Treatment

236 citations, July 2001 in “Trends in Molecular Medicine”

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

research Female Pattern Hair Loss

226 citations, September 2001 in “Journal of The American Academy of Dermatology”

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

research A Randomized, Placebo-Controlled Trial of 5% and 2% Topical Minoxidil Solutions in the Treatment of Female Pattern Hair Loss

219 citations, March 2004 in “Journal of The American Academy of Dermatology”

5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.

The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

research The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

215 citations, November 2006 in “Journal of The American Academy of Dermatology”

Dutasteride more effective for hair growth, but has more side effects than finasteride.

research The Diagnosis and Treatment of Iron Deficiency and Its Potential Relationship to Hair Loss

207 citations, April 2006 in “Journal of The American Academy of Dermatology”

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

research Prevalence of Male and Female Pattern Hair Loss in Maryborough

193 citations, August 2005 in “Journal of Investigative Dermatology Symposium Proceedings”

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Persistent Post COVID-19 Symptoms and Functional Status After 12-14 Weeks of Recovery, Tamil Nadu, India, 2021

Related Community Posts Join

community How does hair loss and recovery work?

community Hair loss products whilst trying to conceive

community Hair loss treatment tier list by Dr Oscar Muñoz

community Hair Loss transformation Min/Fin/DermaStamp Age 23 M.

community Best hair loss treatment to get your hair back!

community Hair Loss Associated with Escitalopram (anti-depressant). Do SSRIs Affect the Hair Follicle?